市场调查报告书
商品编码
1415432
动态心电图机市场:按产品类型、导极类型和最终用户划分 - 全球预测 2024-2030 年Holter ECG Market by Product (Software, Wired Holter ECG Monitors, Wireless Holter ECG Monitors), Lead Type (12-Lead, 3-Lead, 6-Lead), End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
动态心电图市场规模预计2023年为4.4699亿美元,2024年将达到4.7265亿美元,2030年将达到6.7603亿美元,复合年增长率为6.08%。
动态心电图仪的全球市场
主要市场统计 | |
---|---|
基准年[2023] | 44699万美元 |
预测年份 [2024] | 47265万美元 |
预测年份 [2030] | 67603万美元 |
复合年增长率(%) | 6.08% |
动态心电图机是医生用来诊断和监测心律不整患者的医疗设备。这些设备连续记录 24 至 48 小时的心电图 (ECG) 讯号,以检测需要进一步调查或治疗的异常心率或心律不整。随着心血管疾病(CVD)的流行、人口老化和心律不整风险的增加、远端心臟监测技术的进步以及早期诊断和预防性医疗措施意识的提高,动态心电图(Holter)用于正确诊断和治疗变得越来越重要。对高效率医疗设备(包括心电图机)的需求不断增长。然而,动态心电图设备的高成本对小型医疗机构造成了财务障碍。用于远端患者监护的远端医疗监护仪製造商创造了新的机会,以扩大其产品在全球的覆盖范围。
区域洞察
动态心电图机市场正在美洲发展,由于人口老化和心臟病发病率增加,人们越来越关注心臟健康。我们致力于透过研究和技术投资来改善心臟护理,从而提高美洲的诊断能力。在欧盟 (EU),医疗保健提供者正在采用动态心电图等先进技术,透过早期检测心臟疾病来改善患者的治疗结果。在 EMEA(欧洲、中东和非洲)地区,随着各国政府专注于发展医疗保健基础设施和促进医疗旅游,对先进医疗保健服务的需求正在快速增长。非洲人民越来越意识到预防心臟病的措施,增加了对包括心臟心电图在内的诊断解决方案的需求。在亚太地区,医疗设备的研究和开发,加上强调心臟病早期诊断和早期疗育重要性的政府计划和计划,导致该地区的医疗机构越来越多地采用动态心电图监测仪。我是。此外,技术进步和最尖端科技的整合预计将提高精度和准确度,加速全球最终用户对动态心电图的使用。
FPNV定位矩阵
FPNV定位矩阵对于评估动态心电图机市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对动态心电图市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵考察,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1-市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2-市场开拓:我们深入研究利润丰厚的新兴市场,并分析它们在成熟细分市场中的渗透率。
3- 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4-竞争力评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5- 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1-动态心电图机市场的市场规模与预测是多少?
2-动态心电图市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些?
3-动态心电图机市场的技术趋势和法律规范是什么?
4-动态心电图机市场主要厂商的市场占有率是多少?
5-进入动态心电图市场的合适型态和策略手段是什么?
[196 Pages Report] The Holter ECG Market size was estimated at USD 446.99 million in 2023 and expected to reach USD 472.65 million in 2024, at a CAGR 6.08% to reach USD 676.03 million by 2030.
Global Holter ECG Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 446.99 million |
Estimated Year [2024] | USD 472.65 million |
Forecast Year [2030] | USD 676.03 million |
CAGR (%) | 6.08% |
Holter ECG is a medical device that enables physicians to diagnose and monitor patients with heart rhythm disorders. These devices continuously record electrocardiogram (ECG) signals for 24 to 48 hours to detect abnormal heartbeats or arrhythmias requiring further investigation and treatment. Prevalence of cardiovascular diseases (CVDs), increasing aging population with increased risk of arrhythmias, technological advancements in remote cardiac monitoring, and growing awareness regarding early diagnosis and preventive healthcare measures are raising the need for efficient medical devices, including holter ECG, for appropriate diagnosis and treatment. However, the high cost of Holter ECG devices can be a financial barrier for small-scale healthcare facilities. The surge in the adoption of telemedicine services in remote patient monitoring has also created new opportunities for Holter ECG manufacturers to expand their product reach worldwide.
Regional Insights
The Holter ECG market is evolving in the Americas owing to the growing focus on cardiac health due to an aging population and increasing incidences of heart disease. Emphasis on improving cardiac care through investments in research and technology enhances diagnostic capabilities in the Americas. In the European Union, healthcare providers are adopting advanced technologies such as Holter ECG to improve patient outcomes by early detection of heart diseases. The EMEA region has experienced rapid growth in demand for advanced healthcare services with a focus on governments on healthcare infrastructure development and promoting medical tourism. There has been an increasing focus on creating awareness about preventive measures for cardiac conditions among the African population, raising the need for diagnostic solutions, including heart ECG. The APAC region is focusing on medical device research and development coupled with government schemes and programs emphasizing the importance of early diagnosis and intervention for cardiac conditions, which are expanding the deployment of Holter ECG in the healthcare facilities in the region. Besides, the technological advancements and integration of cutting-edge technologies are anticipated to enhance accuracy and precision, thereby accelerating the use of Holter ECG by end-users across the globe.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Holter ECG Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Holter ECG Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Holter ECG Market, highlighting leading vendors and their innovative profiles. These include AlivCor Inc., Bardy Diagnostics, Inc., BPL MEDICAL TECHNOLOGIES PRIVATE LIMITED, Cardiac Insight, Inc., custo med GmbH, EB Neuro S.p.A., Fukuda Denshi Co., Ltd., GE HealthCare Technologies Inc., Hill-Rom Holdings, Inc., iRhythm Technologies, Inc., Koninklijke Philips N.V., LifeSignals Group Inc., Medtronic plc, Nasiff Associates, Inc., Nihon Kohden Corporation, Nissha Co. Ltd., OSI Systems, Inc., SCHILLER AG, Viatom Technology Co. Ltd., and VitalConnect.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Holter ECG Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Holter ECG Market?
3. What are the technology trends and regulatory frameworks in the Holter ECG Market?
4. What is the market share of the leading vendors in the Holter ECG Market?
5. Which modes and strategic moves are suitable for entering the Holter ECG Market?